Consort Medical plc (CSRT.L) (LON:CSRT) Trading 0.5% Higher – Time to Buy?

Consort Medical plc (CSRT.L) (LON:CSRTGet Free Report)’s share price traded up 0.5% during mid-day trading on Thursday . The company traded as high as GBX 1,010 ($12.80) and last traded at GBX 1,010 ($12.80). 768 shares were traded during mid-day trading, a decline of 100% from the average session volume of 520,697 shares. The stock had previously closed at GBX 1,005 ($12.74).

Consort Medical plc (CSRT.L) Stock Up 0.5 %

The company has a debt-to-equity ratio of 55.58, a current ratio of 1.83 and a quick ratio of 1.16. The stock has a market cap of £504.60 million and a price-to-earnings ratio of 127.85. The firm’s 50-day moving average is GBX 1,010 and its 200 day moving average is GBX 1,010.

Consort Medical plc (CSRT.L) Company Profile

(Get Free Report)

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.

Read More

Receive News & Ratings for Consort Medical plc (CSRT.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc (CSRT.L) and related companies with MarketBeat.com's FREE daily email newsletter.